A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan
Clinical trial NCT03273790 · COMPLETED
Trial details
- NCT number
- NCT03273790
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-01
- Primary completion
- 2017-12-31
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.